These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29440892)

  • 21. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
    Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
    Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
    Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
    Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
    Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
    J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.
    Youm I; Agrahari V; Murowchick JB; Youan BB
    Pharm Res; 2014 Sep; 31(9):2439-52. PubMed ID: 24643931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
    Mehra NK; Jain NK
    J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
    Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
    J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy
    Wu Y; Li K; Kong L; Tang Y; Li G; Jiang W; Shen M; Guo R; Zhao Q; Shi X
    Bioconjug Chem; 2020 Oct; 31(10):2404-2412. PubMed ID: 33001643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.
    Zhang Y; Zhou J; Yang C; Wang W; Chu L; Huang F; Liu Q; Deng L; Kong D; Liu J; Liu J
    Int J Nanomedicine; 2016; 11():1119-30. PubMed ID: 27051287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid protected silver nanocarriers for targeted drug delivery.
    Wang Y; Newell BB; Irudayaraj J
    J Biomed Nanotechnol; 2012 Oct; 8(5):751-9. PubMed ID: 22888745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H; Tagami T; Hattori K; Ozeki T
    J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
    Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of a functionalized dipeptide for targeted delivery and pH-sensitive release of chemotherapeutics.
    Kiran S; Dwivedi P; Khatik R; Hameed S; Dwivedi M; Huang F; Xu RX
    Chem Commun (Camb); 2019 Dec; 56(2):285-288. PubMed ID: 31808487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid functionalized reduction-responsive magnetic chitosan nanocapsules for targeted delivery and triggered release of drugs.
    Zhong S; Zhang H; Liu Y; Wang G; Shi C; Li Z; Feng Y; Cui X
    Carbohydr Polym; 2017 Jul; 168():282-289. PubMed ID: 28457451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.
    Mahalunkar S; Yadav AS; Gorain M; Pawar V; Braathen R; Weiss S; Bogen B; Gosavi SW; Kundu GC
    Int J Nanomedicine; 2019; 14():8285-8302. PubMed ID: 31802866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-tumor and renoprotection study of E-[c(RGDfK)
    Zhang B; Zhang Y; Dang W; Xing B; Yu C; Guo P; Pi J; Deng X; Qi D; Liu Z
    J Nanobiotechnology; 2022 Sep; 20(1):425. PubMed ID: 36153589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.